Literature DB >> 2040332

Coronary artery spasm induced by 5-fluorouracil.

R J Luwaert1, O Descamps, F Majois, J M Chaudron, M Beauduin.   

Abstract

We report a case of coronary artery spasm induced by 5-fluorouracil. The symptoms occurred during continuous intravenous infusion of the drug, and a coronary spasm was visualized at angiography.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2040332     DOI： 10.1093/oxfordjournals.eurheartj.a059919

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  25 in total

1.  Images in emergency medicine: Acute severe coronary spasm associated with 5-fluorouracil chemotherapy.

Authors:  S Duran; S Bulur; S Bahadir Sozen; C Bilir; C Uyan; R Akdemir
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

2.  A case of variant angina in a patient under chronic treatment with sorafenib.

Authors:  Italo Porto; Andrea Leo; Luca Miele; Maurizio Pompili; Raffaele Landolfi; Filippo Crea
Journal:  Nat Rev Clin Oncol       Date:  2010-05-18       Impact factor: 66.675

3.  Sustained Disease Control with TOMOXIRI Regimen in a Patient with Metastatic Pancreatic Adenocarcinoma.

Authors:  Sara De Dosso; Patrizia Melchiorre; Chiara Della Badia; Giorgio Moschovitis; Piercarlo Saletti
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 4.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 5.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

6.  Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy.

Authors:  Christopher James Little; Bao Sean Nguyen; Pamela J Tsing
Journal:  Fed Pract       Date:  2021-05

7.  Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.

Authors:  Merete Vaage-Nilsen; Dorte L Nielsen; Anne Dyhl-Polk; Morten Schou; Kirsten K Vistisen; Anne-Sophie Sillesen; Eva Serup-Hansen; Jens Faber; Tobias W Klausen; Stig E Bojesen
Journal:  Oncologist       Date:  2020-10-07

Review 8.  Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.

Authors:  Umberto Campia; Ana Barac
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

9.  Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity.

Authors:  Michael G Fradley; Conor D Barrett; John R Clark; Sanjeev A Francis
Journal:  Tex Heart Inst J       Date:  2013

10.  What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review.

Authors:  Aneta Aleksova; Giulia Gagno; Alessandro Pierri; Carla Todaro; Alessandra Lucia Fluca; Valentina Orlando; Alessandra Guglielmi; Antonio Paolo Beltrami; Gianfranco Sinagra
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.